Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-02-01 / HBPD INT 2006 Feb;5(1):22-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-02-01 / HBPD INT 2006 Feb;5(1):22-72006-02-01 00:00:002019-02-15 09:17:43Recent advances in heat shock protein-based cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-67https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-672006-02-01 00:00:002020-06-23 09:36:57A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-82006-01-21 00:00:002019-02-15 08:38:17Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-18 / Vaccine 2006 Feb;24(7):887-96https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-18 / Vaccine 2006 Feb;24(7):887-962006-01-18 00:00:002019-02-15 08:37:42Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-70https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-702006-01-17 00:00:002019-02-15 09:19:51Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-05 / Breast Cancer Res. 2006;8(1):101https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-05 / Breast Cancer Res. 2006;8(1):1012006-01-05 00:00:002019-02-15 08:44:41Dendritic cell defects in patients with cancer: mechanisms and significance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Cytotherapy 2006;8(3):277-89https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Cytotherapy 2006;8(3):277-892006-01-01 00:00:002019-02-15 08:51:01Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-77https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-772006-01-01 00:00:002006-01-01 00:00:00Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Surg. Today 2006;36(6):559-62https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Surg. Today 2006;36(6):559-622006-01-01 00:00:002019-02-15 08:36:22Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-10https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-102006-01-01 00:00:002019-02-15 08:37:43Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Cytotherapy 2006;8(4):318-26https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Cytotherapy 2006;8(4):318-262006-01-01 00:00:002019-02-15 08:45:56Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Cytotherapy 2006;8(6):580-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Cytotherapy 2006;8(6):580-82006-01-01 00:00:002019-02-15 09:03:05Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Immunol. Res. 2006;36(1-3):265-74https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Immunol. Res. 2006;36(1-3):265-742006-01-01 00:00:002019-02-15 09:15:12Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model
Recent advances in heat shock protein-based cancer vaccines
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes
Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
Dendritic cell defects in patients with cancer: mechanisms and significance
Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma
Immunotherapy for prostate cancer
Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
Genetically modified dendritic cells for therapeutic immunity
Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination
Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model